For years, global life science companies have focused on a familiar set of European markets for expansion. That conversation is changing as Latvia gains attention for its EU access, skilled workforce and growing biomedicine ecosystem. This webinar will explore why Latvia is emerging as a life science investment destination and what organizations should know when evaluating it for European expansion.
Tucked at the crossroads of Northern and Eastern Europe, Latvia offers a combination of agility, access and ambition that can be harder to find in larger, more established markets. It sits within the EU, with regulatory alignment, a highly educated multilingual workforce and a competitive business environment. And yet it remains, for many decision-makers, an undiscovered opportunity.
Latvia’s biomedicine sector has grown significantly over the past several years, not just in size, but in depth and sophistication. World-class research institutions, a strong university pipeline, dedicated Special Economic Zones, and a national innovation platform built to translate science into commercial solutions are all part of an ecosystem that is maturing quickly. Global companies across pharmaceuticals, diagnostics, genomics, digital health, and shared services have already made Latvia their European base and continue to grow there.
In this webinar, the LIAA Investment Attraction team will share what that journey looks like from the inside: what draws international companies to Latvia, what they find when they arrive and how LIAA supports them at every stage, from the first conversation through site selection, regulatory navigation, talent access and long-term growth.
Attendees will gain a practical view of Latvia’s life science investment landscape, including its biomedicine ecosystem, operating environment, talent base, incentive structures and role as a potential European location for R&D, manufacturing, clinical operations or shared services.
Register for this webinar to learn why Latvia is emerging as a life science investment destination for European expansion.
Speakers
Deniss Čamovs, Head of Investment Promotion Division, Investment and Development Agency of Latvia (LIAA) / Invest in Latvia
Deniss Čamovs is the Head of the Investment Promotion Division at the Investment and Development Agency of Latvia (LIAA), where he leads the agency’s strategic mission to attract world-class foreign direct investment into Latvia’s priority sectors. A recognised leader in international investment attraction, Deniss has built a strong track record of forging high-impact partnerships between global companies and Latvia’s growing innovation ecosystem. His work is central to positioning Latvia as one of Europe’s most compelling destinations for life science, biomedicine and technology investment.
Message Presenter
Annija Veinsteina, Senior Investment Advisor – Biomedicine & Life Sciences, Investment and Development Agency of Latvia (LIAA) / Invest in Latvia
Annija Veinsteina is a Senior Investment Advisor at the Investment and Development Agency of Latvia (LIAA), specialising in biomedicine and life science investment attraction. She works at the intersection of global investment and local innovation, building connections between international companies, research institutions and government partners that turn interest in Latvia into action. With an MBA and deep experience in cross-border partnerships, Anni brings both a strategic perspective and genuine on-the-ground knowledge to every conversation about investing in Latvia.
Message PresenterWho Should Attend?
This webinar will appeal to:
- C-suite Executives and senior decision-makers in pharma, biotech, medtech and digital health
- Site Selection and Real Estate professionals evaluating European investment locations
- Shared Services and Global Business Services leaders exploring EU-based expansion
- R&D Directors, Clinical Operations Leads and Heads of Manufacturing
- Corporate Strategy, Business Development and M&A professionals
- Investors and Venture Capital professionals active in life sciences
- Economic Development and Investment Promotion professionals
What You Will Learn
Attendees will gain insight into:
- What makes Latvia a genuinely differentiated investment destination within the EU, and why global life science companies are choosing it over more familiar alternatives
- Latvia’s biomedicine ecosystem: the talent, the research infrastructure, the incentives and the practical realities of operating there
- How LIAA works as a hands-on partner throughout the investment journey, not just at the beginning, but for the long term
- Concrete next steps for organisations who want to explore Latvia as their next European location
Xtalks Partners
Xtalks Pharmaville
Pharmaville is where global life science leaders come to discover the regions shaping the future of research, manufacturing and clinical trials. Built as an extension of Xtalks — The Life Science Community™, our platform connects governments, economic development agencies and industry stakeholders with the decision-makers who determine where the next wave of investment will happen.
For over 20 years, Xtalks has been trusted by hundreds of thousands of senior professionals across pharma, biotech, medtech and healthcare to make informed business decisions. Pharmaville brings that trusted network together with targeted, high-impact digital campaigns to position your region for visibility, credibility and growth on the global stage.
Pharmaville combines targeted webinar programs with ongoing digital visibility through editorial coverage, sponsored features and our Smart Locator to ensure your region is seen when life science investment decisions are being made. Our mission is simple: to ensure your region is seen by the right people at the right time — when they are making the decisions that shape the future.
Latvia
The Investment and Development Agency of Latvia (LIAA) is Latvia’s national investment promotion agency, established in 1993 under the Ministry of Economics. LIAA works with international companies at every stage of their investment journey, from first exploration through market entry, site selection, regulatory support, and long-term growth. Biomedicine is one of LIAA’s defined priority sectors, and the agency brings dedicated expertise, direct government connections, and a genuine commitment to making investment in Latvia work. For companies considering Latvia as their next European location, LIAA is the first call to make.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account